hotspot -WSS

hotspot

author：hotspot 2025-09-14 10:08:39 - browse：7175

Illustration: Alex Hogan/STAT; Photo: Courtesy Perrigo

It’s not every day that a marketing team is tasked with designing the branding and packaging of the first over-the-counter birth control pill to be sold in the U.S.

This was the challenge, and the opportunity, faced by the team behind Opill, the landmark pill from drugmaker Perrigo that received approval from the Food and Drug Administration earlier this month. Their brief: Create a design that would stand out in America’s notoriously sprawling pharmacy aisles; inspire trust and confidence; be easy to remember and recognize; appeal to women — including teenagers — as well as trans men and nonbinary people; clearly communicate its purpose; be simple to carry and use; contain straightforward but accurate user information; and clear FDA requirements.

Settling on the right approach took years of research and testing, which resulted in the name Opill and packaging featuring bright teal, saturated pink, and yellow, as well as a rounded font reminiscent of millennials’ ubiquitous favorite Gotham. All of these features are intended to set the product apart from the dozens of prescription contraceptive pills available in the U.S. market and internationally.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： AstraZeneca stays mum on Medicare drug pricing negotiations

explore

WSS

The Bio Revolution is changing business and society

Congress: Prevent baby formula shortages by passing a new bill

Asahi Kasei to buy Calliditas, picking up kidney disease drug

Why we need mandatory labeling of GMO products

The HPV vaccine prevents cancer in men, too. Why do so few people get it?

Readout LOUD: Venture capital, Gilead, and more M&A

focus

hotspot

entertainment

Apple is now the first public company to be valued at $3 trillion

Stroke rates rising, especially in working

State Dept. review finds Biden bears some blame for Afghanistan failures

Readout Newsletter: Amgen, Regeneron, BGI Group and more

Virginia high school admissions case could be legal follow

Congress: Prevent baby formula shortages by passing a new bill

How to save PrEP access — and even expand it

Unique patient identifier: Experts argue the benefits, pitfalls

Drug repurposing or repositioning? The language matters

Richard Slayman had a rejection episode of his pig kidney before leaving hospital

Wikipedia

Novo Holdings to buy drug manufacturer Catalent in $16.5B deal

Surgery pushed Ben Carson to fame

J&J reports mixed data on next

U.S. death rates show how politics are affecting public health

Asahi Kasei to buy Calliditas, picking up kidney disease drug

Surgery pushed Ben Carson to fame

explore

hotspot

explore

focus